Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.

@article{Levine1996LowDM,
  title={Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.},
  author={Alexandra M. Levine and Anil Tulpule and Byron M. Espina and William Boswell and Jonathan Buckley and Suraiya Rasheed and Steve Stain and Jody Parker and Bharat N. Nathwani and P. S. Gill},
  journal={Cancer},
  year={1996},
  volume={78 3},
  pages={517-26}
}
BACKGROUND Use of multiagent chemotherapy has been associated with complete remission (CR) in approximately 50% of patients with newly diagnosed acquired immunodeficiency syndrome (AIDS)-lymphoma, although additional AIDS-related complications may occur. Both chemotherapy and antiretroviral therapy were employed in an attempt to ascertain if the combination was safe, and associated with changes in human immunodeficiency virus (HIV) p24 antigen levels during the course of treatment. METHODS… CONTINUE READING